Misato Okamura
Hokkaido University(JP)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Tuberculosis Research and Epidemiology, Intracerebral and Subarachnoid Hemorrhage Research, Nerve injury and regeneration
Most-Cited Works
- → Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases(2018)92 cited
- → Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies(2019)66 cited
- → Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody(2019)44 cited
- → Severe exacerbation or manifestation of primary disease related to nivolumab in non-small-cell lung cancer patients with poor performance status or brain metastases(2016)40 cited
- → Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors(2020)38 cited
- → Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors(2020)28 cited
- → Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review(2021)28 cited
- → Diagnostic usefulness of an amino acid tracer, α-[N-methyl-11C]-methylaminoisobutyric acid (11C-MeAIB), in the PET diagnosis of chest malignancies(2013)24 cited
- → Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study(2022)16 cited
- → Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer(2021)13 cited